NL-OMON30431已完成2 期
Protect: Clinical evaluation of pacing during the onset of revascularization. Clinical feasibility study - Protect
Guidant Europe n.v. a Boston0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •patients presenting with their first clinically documented MI in whom the clinical decision was made to treat with PCI
- •patients older than 17 years
- •patients in whom the time from symptom onset to hospital admission is minimal 1 hour - maximal 6 hours
- •patients willing and capable of providing informed consent
排除标准
- •patients receiving thrombolytics upon clinical presentation
- •patients having previous unstable angina or ACS
- •patients having a previous PCI and/or CABG
- •clinically and hemodynamically unstable requiring circulatory support
- •Patients with a history of VF
- •Patients with a heartrate above 120 bpm at the time of enrollment
研究者
相似试验
招募中
不适用
Efficacy of physiological pacing in patients with bradycardia and/or conduction system disturbanceBradycardia and/or conduction system disturbanceJPRN-UMIN000040622Kyorin University240
招募中
不适用
Efficacy of closed loop stimulation pacing in patients with heart failurechronic heart failureJPRN-UMIN000038879ippon Medical School Musashi-Kosugi Hospital30
招募中
1 期
Safety evaluation of the preemptive immune-cell therapy against cancer.JPRN-jRCTc030230349Goto Shigenori650
招募中
1 期
Safety evaluation of the preemptive immune-cell therapy against cancer.JPRN-jRCTc030190261Goto Shigenori650
尚未招募
2 期
To study the effect of prophylactic zinc in prevention of respiratory infections and Diarrhoea among children.CTRI/2022/09/045346Dr Arnab Ghorui